Hepatitis B virus e antigen specific epitopes and limitations of commercial anti-HBe immunoassays

Journal of Medical Virology

Volumn 60, Issue 3, 2000, Pages 256-263

  Baumeister, Mark A ^a   Medina Selby, Angelica ^a   Coit, Doris ^a   Nguyen, Steve ^a   George Nascimento, Carlos ^a   Gyenes, Alexander ^a   Valenzuela, Pablo ^a   Kuo, George ^a   Chien, David Y ^a  

^a NOVARTIS PHARMA AG   (Switzerland)

Author keywords

Epitope; Neutralization; Reactivity; Seroconversion

Indexed keywords

EPITOPE; HEPATITIS B(E) ANTIBODY; HEPATITIS B(E) ANTIGEN;

ANTIBODY DETECTION; ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITOPE MAPPING; HEPATITIS B VIRUS; HUMAN; IMMUNOASSAY; SEROCONVERSION;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODY SPECIFICITY; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITOPE MAPPING; HEPATITIS B CORE ANTIGENS; HEPATITIS B E ANTIGENS; HEPATITIS B VIRUS; HUMANS; IMMUNE SERA; IMMUNOASSAY; MICE; RABBITS; REAGENT KITS, DIAGNOSTIC; SEROLOGIC TESTS;

EID: 0033958245     PISSN: 01466615     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9071(200003)60:3<256::AID-JMV2>3.0.CO;2-H     Document Type: Article

References (21)

1. Bonino F, Brunetto MR, Rizetto M, Will H. 1991. Hepatitis B virus unable to secrete e antigen. Gastroenterology 100:1138-1141.
2. Bottcher B, Wynne SA, Crowther RA. 1997. Determination of the fold of the core protein of hepatitis B virus by electron cryomicroscopy. Nature 386:88-91.
3. Broker M, Noah M, Nassal M, Dietz S, Ochs J, Bauml O, Waldinger K, Bodenbenner M, Schott U, Grote M. 1993. Expression of hepatitis core gene products with specific immunoreactivity for e antigen (HBeAg) in Saccharomyces cereuisiae. J Biotechnol 29:243-255.
4. Chien DY, McFarland J, Tabrizi A, Kuo C, Houghton M, Kuo G. 1994. Distinct subtypes of hepatitis C virus defined by antibodies directed to the putative core, NS4 and NS5 region polypeptides. In: Nishioka K, Suzuki H, Mishiro S, Oda T, editors. Viral Hepatitis and Liver Disease. New York: Springer-Verlag, p 320-324.
5. Evans AA, Fine M, London WT. 1997. Spontaneous seroconversion in hepatitis B e antigen-positive chronic hepatitis B: implications for interferon therapy. J Infect Dis 176:845-850.
6. Ferns RB, Tedder RS. 1986. Human and monoclonal antibodies to hepatitis B core antigen recognize a single immunodominant epitope. J Med Virol 19:193-203.
7. Hallewell RA, Masiarz FR, Najarian RJ, et al. 1985. Human Cu/Zn superoxide cDNA: isolation of clones synthesizing high levels of active or inactive enzyme from an expression library. Nucleic Acids Res 13:2017.
8. Hallewell RA, Laria I, Tabrizi A, Carlin G, Getzoff ED, Tainer JA, Cousens LS, Mullenbach GT. 1989. Genetically engineered polymers of human CuZn superoxide dismutase. J Biol Chem 264: 5260-5268.
9. Inada T, Misumi Y, Seno M, Kanezaki S, Shibata Y, Oka Y, Onda H. 1989. Synthesis of hepatitis B virus e antigen in E. coli. Virus Res 14:27-48.
10. Kurai K, Iino S, Kurokawa K, Shimoda K, Hino K. 1991. Large molecular form of serum HBeAg in chronic hepatitis B virus infection: relation to liver cell damage. Hepatology 18:1057-1060.
11. Maruyama T, McLachian A, Iino S, Koike K, Kurokawa K, Milich DR. 1993. The serology of chronic hepatitis B infection revisited. J Clin Invest 91:2586-2595.
12. McKay P, Lees J, Murray K. 1981. The conversion of hepatitis B core antigen synthesized in E. coli into e antigen. J Med Virol 8:237-243.
13. Milich DR, Jones JE, Hughes JL, Price J, Raney AK, McLachlan A. 1990. Is a function of the secreted hepatitis B e antigen to induce immunologic tolerance in utero? Proc Natl Acad Sci USA 87:6599-6603.
14. Nassal M, Rieger A. 1993. An intramolecular disulfide bridge between Cys-7 and Cys-61 determines the structure of the secretory core gene product (e antigen) of hepatitis B virus. J Virol 67:4307-4315.
15. Ou JH, Laub O, Rutter WJ. 1986. Hepatitis B virus gene function: the precore region targets the core antigen to cellular membranes and causes the secretion of the e antigen. Proc Natl Acad Sci USA 83:1578-1582.
16. Salfeld J, Pfaff M, Noah M, Schaller H. 1989. Antigenic determinants and functional domains in core antigen and e antigen from hepatitis B virus. J Virol 63:798-808.
17. Sallberg M, Ruden U, Wahren B, Noah M, Magnius LO. 1991. Human and murine B-cells recognize the HBeAg/beta (or HBe2) epitope as a linear determinant. Mol Immunol 28:719-726.
18. Sallberg M, Pushko P, Berzinsh I, Bichko V, Sillekens P, Noah M, Pumpens P, Grens E, Wahren B, Magnius LO. 1993. Immunochemical structure of the carboxy-terminal part of hepatitis B e antigen: identification of internal and surface-exposed sequences. J Gen Virol 74:1335-1340.
19. Standring DN, Ou JH, Masiarz FR, Rutter WJ. 1988. A signal peptide encoded within the precore region of hepatitis B virus directs the secretion of heterogeneous population of e antigens in Xenopus oocytes. Proc Natl Acad Sci USA 85:8405-8409.
20. Tordjeman M, Fontan G, Rabillon V, Martin J, Trepo C, Hoffenbach A, Mabrouk K, Sabatier JM, Van Rietschoten J, Somme G. 1993. Characterization of minor and major antigenic regions within the hepatitis B virus nucleocapsid. J Med Virol 41:221-229.
21. Uy A, Bruss V, Gerlich WH, Kochel HG, Thomssen R. 1986. Precore sequence of hepatitis B virus inducing e antigen and membrane association of the viral core protein. Virology 155:89-96.